Received Jan 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
was painful/second one was worse than the first; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: was painful/second one was worse than the first). The outcome of the pain was not reported. It was unknown if the reporter considered the pain to be related to Shingles vaccine. It was unknown if the company considered the pain to be related to Shingles vaccine. Linked case(s) involving the same patient: US2026AMR007092 Additional Information: GSK Receipt Date: 10-JAN-2026 This case was reported by a patient via interactive digital media. The vaccine was painful and especially the next day, second one was worse than the first. The batch number was not provided and unable to contact the reporter.; Sender's Comments: US-GSK-US2026AMR007092:Case for 1st dose